281 related articles for article (PubMed ID: 28781723)
1. Developing a Comprehensive Cardio-Oncology Program at a Cancer Institute: The Moffitt Cancer Center Experience.
Fradley MG; Brown AC; Shields B; Viganego F; Damrongwatanasuk R; Patel AA; Hartlage G; Roper N; Jaunese J; Roy L; Ismail-Khan R
Oncol Rev; 2017 Jun; 11(2):340. PubMed ID: 28781723
[TBL] [Abstract][Full Text] [Related]
2. A comprehensive pediatric cardio-oncology program: a single institution approach to cardiovascular care for pediatric patients with cancer and childhood cancer survivors.
Hernandez NB; Shliakhtsitsava K; Tolani D; Cochran C; Butts R; Bonifacio J; Journey E; Oppenheim JN; Pennant SG; Arnold K; McCaskill T; Bowers DC
Cardiooncology; 2024 Apr; 10(1):20. PubMed ID: 38582914
[TBL] [Abstract][Full Text] [Related]
3. Rationale for setting up a cardio-oncology unit: our experience at Mayo Clinic.
Barros-Gomes S; Herrmann J; Mulvagh SL; Lerman A; Lin G; Villarraga HR
Cardiooncology; 2016 Apr; 2(1):5. PubMed ID: 33530144
[TBL] [Abstract][Full Text] [Related]
4. The Cardio-oncology Program: A Multidisciplinary Approach to the Care of Cancer Patients With Cardiovascular Disease.
Parent S; Pituskin E; Paterson DI
Can J Cardiol; 2016 Jul; 32(7):847-51. PubMed ID: 27343743
[TBL] [Abstract][Full Text] [Related]
5. Exercise Cardio-Oncology: Exercise as a Potential Therapeutic Modality in the Management of Anthracycline-Induced Cardiotoxicity.
Kang DW; Wilson RL; Christopher CN; Normann AJ; Barnes O; Lesansee JD; Choi G; Dieli-Conwright CM
Front Cardiovasc Med; 2021; 8():805735. PubMed ID: 35097024
[TBL] [Abstract][Full Text] [Related]
6. Developing Cardio-Oncology Programs in the New Era: Beyond Ventricular Dysfunction Due to Cancer Treatments.
Pons-Riverola A; Morillas H; Berdejo J; Pernas S; Pomares H; Asiain L; Garay A; Fernandez-Ortega A; Oliveira AC; Martínez E; Jiménez-Marrero S; Pina E; Fort E; Ramos R; Alcoberro L; Hidalgo E; Antonio-Rebollo M; Alcober L; Enjuanes Grau C; Comín-Colet J; Moliner P
Cancers (Basel); 2023 Dec; 15(24):. PubMed ID: 38136428
[TBL] [Abstract][Full Text] [Related]
7. What Does a Cardio-oncology Service Offer to the Oncologist and the Haematologist?
Andres MS; Pan J; Lyon AR
Clin Oncol (R Coll Radiol); 2021 Aug; 33(8):483-493. PubMed ID: 33832839
[TBL] [Abstract][Full Text] [Related]
8. Organization and implementation of a cardio-oncology program.
Fiuza M; Ribeiro L; Magalhães A; Sousa AR; Nobre Menezes M; Jorge M; Costa L; Pinto FJ
Rev Port Cardiol; 2016 Sep; 35(9):485-94. PubMed ID: 27503589
[TBL] [Abstract][Full Text] [Related]
9. Prevention of Cardiotoxicities With Traditional and Novel Chemotherapeutic Agents.
Sharalaya Z; Collier P
Curr Heart Fail Rep; 2018 Aug; 15(4):260-269. PubMed ID: 29938321
[TBL] [Abstract][Full Text] [Related]
10. A virtual-hybrid approach to launching a cardio-oncology clinic during a pandemic.
Brown SA; Patel S; Rayan D; Zaharova S; Lin M; Nafee T; Sunkara B; Maddula R; MacLeod J; Doshi K; Meskin J; Marks D; Saucedo J
Cardiooncology; 2021 Jan; 7(1):2. PubMed ID: 33441188
[TBL] [Abstract][Full Text] [Related]
11. Cardio-oncology: rationale, aims and future directions.
Pan J; Garza F; Lyon AR
Curr Opin Support Palliat Care; 2021 Jun; 15(2):134-140. PubMed ID: 33605633
[TBL] [Abstract][Full Text] [Related]
12. Cardio-Oncology Fellowship Training and Education.
Fradley MG
Curr Treat Options Cardiovasc Med; 2019 May; 21(6):27. PubMed ID: 31104193
[TBL] [Abstract][Full Text] [Related]
13. Modern concepts in cardio-oncology.
Rassaf T; Totzeck M
J Thorac Dis; 2018 Dec; 10(Suppl 35):S4386-S4390. PubMed ID: 30701105
[TBL] [Abstract][Full Text] [Related]
14. Modeling Precision Cardio-Oncology: Using Human-Induced Pluripotent Stem Cells for Risk Stratification and Prevention.
Perry TR; Roberts ML; Sunkara B; Maddula R; McLeish T; Gomez J; Lucas J; Rayan D; Patel S; Liang M; Bosnjak ZJ; Brown SA
Curr Oncol Rep; 2021 May; 23(7):77. PubMed ID: 33937943
[TBL] [Abstract][Full Text] [Related]
15. Cardio-Oncology Care Delivered in the Non-academic Environment.
Arnold AM; Skurka K
Curr Treat Options Oncol; 2022 May; 23(5):762-773. PubMed ID: 35349050
[TBL] [Abstract][Full Text] [Related]
16. Update on cardio-oncology: Novel cancer therapeutics and associated cardiotoxicities.
Guha A; Armanious M; Fradley MG
Trends Cardiovasc Med; 2019 Jan; 29(1):29-39. PubMed ID: 29910109
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and Management of Cancer Treatment-Related Cardiac Dysfunction and Heart Failure in Children.
Hegazy M; Ghaleb S; Das BB
Children (Basel); 2023 Jan; 10(1):. PubMed ID: 36670699
[TBL] [Abstract][Full Text] [Related]
18. Gender Differences in Diagnosis, Prevention, and Treatment of Cardiotoxicity in Cardio-Oncology.
Simek S; Lue B; Rao A; Ravipati G; Vallabhaneni S; Zhang K; Zaha VG; Chandra A
J Clin Med; 2022 Sep; 11(17):. PubMed ID: 36079097
[TBL] [Abstract][Full Text] [Related]
19. Intersecting care through specialized pharmacists: A case report of residency rotation focused on the new horizon of cardio-oncology.
Einsfeld L; do Canto Olegário I; Fagundes ML
Curr Pharm Teach Learn; 2023 May; 15(5):508-513. PubMed ID: 37183144
[TBL] [Abstract][Full Text] [Related]
20. Cardio-oncology: an ongoing evolution.
Petek BJ; Greenman C; Herrmann J; Ewer MS; Jones RL
Future Oncol; 2015; 11(14):2059-66. PubMed ID: 26198836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
